{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:38:13Z","timestamp":1790815093914,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00192-025-06514-2","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T14:28:25Z","timestamp":1769092105000},"page":"2095-2104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Responsiveness, Minimal Detectable Change, and Minimal Clinically Important Difference of the Turkish Version of the 8-item Overactive Bladder Questionnaire"],"prefix":"10.1007","volume":"37","author":[{"given":"Seyda Toprak","family":"Celenay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4476-3785","authenticated-orcid":false,"given":"Erhan","family":"Secer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Karaaslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehra","family":"Korkut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya Ozer","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"issue":"1","key":"6514_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/nau.20798","volume":"29","author":"BT Haylen","year":"2010","unstructured":"Haylen BT, De Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4\u201320.","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"6514_CR2","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/JU.0000000000000309","volume":"202","author":"DJ Lightner","year":"2019","unstructured":"Lightner DJ, Gomelsky A, Souter L, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline amendment 2019. J Urol. 2019;202(3):558\u201363.","journal-title":"J Urol"},{"issue":"6","key":"6514_CR3","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1023\/A:1016370925601","volume":"11","author":"K Coyne","year":"2002","unstructured":"Coyne K, Revicki D, Hunt T, Corey R, Stewart W, Bentkover J, et al. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res. 2002;11(6):563\u201374.","journal-title":"Qual Life Res"},{"issue":"8","key":"6514_CR4","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1007\/s00192-023-05551-z","volume":"34","author":"S Uguzova","year":"2023","unstructured":"Uguzova S, Julieb\u00f8-Jones P, Beisland C, Haq A. Current status of patient-reported outcome measures and other subjective assessment grading tools in bladder pain syndrome. Int Urogynecol J. 2023;34(8):1677\u201387.","journal-title":"Int Urogynecol J"},{"key":"6514_CR5","unstructured":"Portney LG, Watkins MP. Foundations of clinical research: applications to practice: Pearson\/Prentice Hall Upper Saddle River, NJ; 2009."},{"key":"6514_CR6","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/S0895-4356(96)00207-7","volume":"49","author":"JG Wright","year":"1996","unstructured":"Wright JG. The minimal important difference: who\u2019s to say what is important? J Clin Epidemiol. 1996;49:1221\u20132.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"6514_CR7","first-page":"45","volume":"40","author":"MH Liang","year":"2002","unstructured":"Liang MH, Lew RA, Stucki G, Fortin PR, Daltroy L. Measuring clinically important changes with patient-oriented questionnaires. Med Care. 2002;40(4):45\u201351.","journal-title":"Med Care"},{"issue":"4","key":"6514_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/HTR.0000000000000184","volume":"31","author":"T Mallinson","year":"2016","unstructured":"Mallinson T, Pape TL, Guernon A. Responsiveness, minimal detectable change, and minimally clinically important differences for the disorders of consciousness scale. J Head Trauma Rehabil. 2016;31(4):43\u201351.","journal-title":"J Head Trauma Rehabil"},{"issue":"2","key":"6514_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/NPT.0b013e318219308c","volume":"35","author":"M Beninato","year":"2011","unstructured":"Beninato M, Portney LG. Applying concepts of responsiveness to patient management in neurologic physical therapy. J Neurol Phys Ther. 2011;35(2):75\u201381.","journal-title":"J Neurol Phys Ther"},{"issue":"5","key":"6514_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2165\/00019053-200018050-00001","volume":"18","author":"RD Hays","year":"2000","unstructured":"Hays RD, Woolley JM. The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it? Pharmacoeconomics. 2000;18(5):419\u201323.","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"6514_CR11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","volume":"61","author":"D Revicki","year":"2008","unstructured":"Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008;61(2):102\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"6514_CR12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.5014\/ajot.2013.006015","volume":"67","author":"WJ Coster","year":"2013","unstructured":"Coster WJ. Making the best match: selecting outcome measures for clinical trials and outcome studies. Am J Occup Ther. 2013;67(2):162\u201370.","journal-title":"Am J Occup Ther"},{"issue":"21","key":"6514_CR13","first-page":"113","volume":"21","author":"T Tarcan","year":"2012","unstructured":"Tarcan T, Mang\u0131r N, \u00d6zg\u00fcr M\u00d6, Akbal C. OAB-V8 A\u015f\u0131r\u0131 aktif mesane sorgulama formu validasyon \u00e7al\u0131\u015fmas\u0131. \u00dcroloji B\u00fclteni. 2012;21(21):113\u20136.","journal-title":"\u00dcroloji B\u00fclteni"},{"issue":"7","key":"6514_CR14","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1111\/jog.13343","volume":"43","author":"S Bunyavejchevin","year":"2017","unstructured":"Bunyavejchevin S. Overactive bladder symptom scores responsiveness before and after anticholinergic treatment in women with overactive bladder: the pilot study. J Obstet Gynaecol Res. 2017;43(7):1189\u201393.","journal-title":"J Obstet Gynaecol Res"},{"issue":"4","key":"6514_CR15","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.urology.2011.06.020","volume":"78","author":"M Gotoh","year":"2011","unstructured":"Gotoh M, Homma Y, Yokoyama O, Nishizawa O. Responsiveness and minimal clinically important change in overactive bladder symptom score. Urology. 2011;78(4):768\u201373.","journal-title":"Urology"},{"issue":"12","key":"6514_CR16","doi-asserted-by":"publisher","first-page":"e032795","DOI":"10.1136\/bmjopen-2019-032795","volume":"9","author":"MH Blanker","year":"2019","unstructured":"Blanker MH, Alma HJ, Devji TS, Roelofs M, Steffens MG, van der Worp H. Determining the minimal important differences in the International Prostate Symptom Score and Overactive Bladder Questionnaire: results from an observational cohort study in Dutch primary care. BMJ Open. 2019;9(12):e032795.","journal-title":"BMJ Open"},{"issue":"12","key":"6514_CR17","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1590\/1806-9282.63.12.1032","volume":"63","author":"F Fitz","year":"2017","unstructured":"Fitz F, Sartori M, Gir\u00e3o MJ, Castro R. Pelvic floor muscle training for overactive bladder symptoms\u2013a prospective study. Rev Assoc Med Bras. 2017;63(12):1032\u20138.","journal-title":"Rev Assoc Med Bras"},{"key":"6514_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2490-12-30","volume":"12","author":"L Viktrup","year":"2012","unstructured":"Viktrup L, Hayes RP, Wang P, Shen W. Construct validation of patient global impression of severity (PGI-S) and improvement (PGI-I) questionnaires in the treatment of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. BMC Urol. 2012;12:30.","journal-title":"BMC Urol"},{"key":"6514_CR19","doi-asserted-by":"crossref","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences: Routledge; 2013.","DOI":"10.4324\/9780203771587"},{"issue":"1","key":"6514_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ajog.2004.12.025","volume":"193","author":"MD Barber","year":"2005","unstructured":"Barber MD, Walters MD, Bump RC. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol. 2005;193(1):103\u201313.","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"6514_CR21","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1007\/s00192-020-04513-z","volume":"32","author":"PK Karjalainen","year":"2021","unstructured":"Karjalainen PK, Mattsson NK, Jalkanen JT, Nieminen K, Tolppanen AM. Minimal important difference and patient acceptable symptom state for PFDI-20 and POPDI-6 in POP surgery. Int Urogynecol J. 2021;32(12):3169\u201376.","journal-title":"Int Urogynecol J"},{"issue":"4","key":"6514_CR22","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.jclinepi.2008.07.009","volume":"62","author":"D Turner","year":"2009","unstructured":"Turner D, Sch\u00fcnemann HJ, Griffith LE, Beaton DE, Griffiths AM, Critch JN, et al. Using the entire cohort in the receiver operating characteristic analysis maximizes precision of the minimal important difference. J Clin Epidemiol. 2009;62(4):374\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"6514_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ejogrb.2012.03.004","volume":"162","author":"PB Kaplan","year":"2012","unstructured":"Kaplan PB, Sut N, Sut HK. Validation, cultural adaptation and responsiveness of two pelvic-floor-specific quality-of-life questionnaires, PFDI-20 and PFIQ-7, in a Turkish population. Eur J Obstet Gynecol Reprod Biol. 2012;162(2):229\u201333.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"6514_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2023.1225850","volume":"14","author":"K Swan","year":"2023","unstructured":"Swan K, Speyer R, Scharitzer M, Farneti D, Brown T, Woisard V, et al. Measuring what matters in healthcare: a practical guide to psychometric principles and instrument development. Front Psychol. 2023;14:1225850.","journal-title":"Front Psychol"},{"issue":"6","key":"6514_CR25","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2522\/ptj.20070214","volume":"88","author":"T Steffen","year":"2008","unstructured":"Steffen T, Seney M. Test-retest reliability and minimal detectable change on balance and ambulation tests, the 36-item short-form health survey, and the unified Parkinson disease rating scale in people with parkinsonism. Phys Ther. 2008;88(6):733\u201346.","journal-title":"Phys Ther"},{"issue":"9","key":"6514_CR26","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.jclinepi.2004.01.012","volume":"57","author":"DT Eton","year":"2004","unstructured":"Eton DT, Cella D, Yost KJ, Yount SE, Peterman AH, Neuberg DS, et al. A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. J Clin Epidemiol. 2004;57(9):898\u2013910.","journal-title":"J Clin Epidemiol"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-025-06514-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-025-06514-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-025-06514-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:52:38Z","timestamp":1784551958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-025-06514-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["6514"],"URL":"https:\/\/doi.org\/10.1007\/s00192-025-06514-2","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by Izmir Katip Celebi University Health Research Ethics Committee (0275).","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}